Table 3.

Multivariable analysis comparing the total score of PsAID-12 (dependent variable) to the potential variables influencing the quality of life in patients with PsA (n = 144).

Independent VariablesCoefficientSErpartialtp
Constant−0.5848
Age, yrs0.0034440.011650.026640.2960.7681
BMI−0.0015440.02796−0.004981−0.05520.9560
cDAPSA0.22420.015510.793514.461< 0.0001
Dactylitis−0.14430.3276−0.03970−0.4410.6602
Fibromyalgia1.70710.31010.44465.505< 0.0001
LEI−0.0017700.1418−0.001126−0.01250.9901
PsA disease duration, yrs0.027540.014590.16781.8880.0613
PsO disease duration, yrs−0.015760.01032−0.1365−1.5280.1291
Educational level, yrs0.052370.027410.16981.9110.0583
PGA0.47390.095120.40974.982< 0.0001
SCQ−0.0017210.03590−0.004322−0.04790.9618
  • PsAID-12: Psoriatic Arthritis Impact of Disease 12 items; PsA: psoriatic arthritis; BMI: body mass index; cDAPSA: clinical Disease Activity index for Psoriatic Arthritis; LEI: Leeds Enthesitis Index; PsO: psoriasis; PGA: physician’s global assessment of psoriasis; SCQ: Self-administered Comorbidity Questionnaire; SE: standard error.